Beam Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 96.46 million compared to USD 69.21 million a year ago. Basic loss per share from continuing operations was USD 1.33 compared to USD 1.01 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.86 USD | -4.08% | +0.66% | -12.02% |
05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.02% | 1.96B | |
+63.72% | 62.59B | |
-2.01% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.38% | 26.21B | |
-22.15% | 19.09B | |
+3.77% | 13.08B | |
+25.52% | 12.26B | |
+26.99% | 12.05B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023